Sfoglia per Autore
Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy
2014-01-01 Cecconetto, L; Casadei Gardini, A; Tenti, E; Maltoni, R; Bravaccini, S; Oboldi, D; Zoli, W; Serra, P; Donati, C; Sarti, S; Amadori, D; Rocca, A.
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer
2014-01-01 Rocca, A; Farolfi, A; Bravaccini, S; Schirone, A; Amadori, D
Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients
2014-01-01 Rambau, P; Masalu, N; Jackson, K; Chalya, P; Serra, P; Bravaccini, S
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations
2014-01-01 Amadori, D; Serra, P; Bravaccini, S; Farolfi, A; Puccetti, M; Carretta, E; Medri, L; Nanni, O; Tumedei, Mm; Kahima, J; Masalu, N
New Biomarkers to Predict the Evolution of In Situ Breast Cancers
2014-01-01 Bravaccini, S; Tumedei, Mm; Scarpi, E; Zoli, W; Rengucci, C; Serra, L; Curcio, A; Buggi, F; Folli, S; Rocca, A; Maltoni, R; Puccetti, M; Amadori, D; Silvestrini, R
Assessment of DNA Damage and Telomerase Activity in Exfoliated Urinary Cells as Sensitive and Noninvasive Biomarkers for Early Diagnosis of Bladder Cancer in Ex-Workers of a Rubber Tyres Industry
2014-01-01 Cavallo, D; Casadio, V; Bravaccini, S; Iavicoli, S; Pira, E; Romano, C; Fresegna, Am; Maiello, R; Ciervo, A; Buresti, G; Zoli, W; Calistri, D
Benefit from anthracyclines in relation to biological profiles in early breast cancer
2014-01-01 Rocca, A; Bravaccini, S; Scarpi, E; Mangia, A; Petroni, S; Puccetti, M; Medri, L; Serra, L; Ricci, M; Cerasoli, S; Biglia, N; Maltoni, R; Giunchi, Dc; Gianni, L; Tienghi, A; Brandi, M; Faedi, M; Sismondi, P; Paradiso, A; Silvestrini, R; Amadori, D
Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast
2015-01-01 Tumedei, Mm; Silvestrini, R; Ravaioli, S; Massa, I; Maltoni, R; Rocca, A; Folli, S; Buggi, F; Curcio, A; Serra, L; Puccetti, M; Amadori, D; Bravaccini, S
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy
2015-01-01 Rocca, A; Andreis, D; Fedeli, A; Maltoni, R; Sarti, S; Cecconetto, L; Pietri, E; Schirone, A; Bravaccini, S; Serra, P; Farolfi, A; Amadori, D
In-111-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance
2015-01-01 Genestreti, G; Bongiovanni, A; Burgio, Ma; Burgio, Sl; Musto, A; Rossi, A; Monti, M; Scarpi, E; Ulivi, P; Bravaccini, S; Dubini, A; Matteucci, F; Gavelli, G
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in patients with different subtypes of breast cancer
2016-01-01 Ravaioli, S; Maltoni, R; Casadio, V; Tumedei, Mm; Foca, F; Salvi, S; Martignano, F; Calistri, D; Rocca, A; Bravaccini, S
ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA
2016-01-01 Bravaccini, S; Tumedei, Mm; Ulivi, P; Zoli, W; Calistri, D; Candoli, P; Amadori, D; Puccetti, M
Androgen receptor signaling pathways as a target for breast cancer treatment
2016-01-01 Pietri, E; Conteduca, V; Andreis, D; Massa, I; Melegari, E; Sarti, S; Cecconetto, L; Schirone, A; Bravaccini, S; Serra, P; Fedeli, A; Maltoni, R; Amadori, D; De Giorgi, U; Rocca, A
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report
2016-01-01 Gardini, Ac; Mariotti, M; Lucchesi, A; Pini, S; Valgiusti, M; Bravaccini, S; Del Monte, A; Burgio, Ma; Marisi, G; Amadori, D; Frassineti, Gl
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy
2016-01-01 Ulivi, P; Chiadini, E; Dazzi, C; Dubini, A; Costantini, M; Medri, L; Puccetti, M; Capelli, L; Calistri, D; Verlicchi, A; Gamboni, A; Papi, M; Mariotti, M; De Luigi, N; Scarpi, E; Bravaccini, S; Turolla, Gm; Amadori, D; Crino, L; Delmonte, A
Frequency of Actionable Alterations in EGFR wt NSCLC: Experience of the Wide Catchment Area of Romagna (AVR)
2017-01-01 Chiadini, E; Delmonte, A; Capelli, L; De Luigi, N; Gamboni, A; Casanova, C; Dazzi, C; Papi, M; Bravaccini, S; Tumedei, Mm; Dubini, A; Puccetti, M; Crino, L; Uliyil, P
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer
2017-01-01 Maltoni, R; Casadio, V; Ravaioli, S; Foca, F; Tumedei, Mm; Salvi, S; Martignano, F; Calistri, D; Rocca, A; Schirone, A; Amadori, D; Bravaccini, S
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization
2017-01-01 Ravaioli, S; Tumedei, Mm; Amadori, A; Puccetti, M; Chiadini, E; Bravaccini, S
Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania
2017-01-01 Masalu, N; Serra, P; Amadori, D; Kahima, J; Majinge, C; Rwehabura, J; Nanni, O; Bravaccini, S; Puccetti, M; Tumino, R; Bucchi, L
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology
2017-01-01 Ravaioli, S; Bravaccini, S; Tumedei, Mm; Pironi, F; Candoli, P; Puccetti, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy | 1-gen-2014 | Cecconetto, L; Casadei Gardini, A; Tenti, E; Maltoni, R; Bravaccini, S; Oboldi, D; Zoli, W; Serra, P; Donati, C; Sarti, S; Amadori, D; Rocca, A. | |
| Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer | 1-gen-2014 | Rocca, A; Farolfi, A; Bravaccini, S; Schirone, A; Amadori, D | |
| Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients | 1-gen-2014 | Rambau, P; Masalu, N; Jackson, K; Chalya, P; Serra, P; Bravaccini, S | |
| Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations | 1-gen-2014 | Amadori, D; Serra, P; Bravaccini, S; Farolfi, A; Puccetti, M; Carretta, E; Medri, L; Nanni, O; Tumedei, Mm; Kahima, J; Masalu, N | |
| New Biomarkers to Predict the Evolution of In Situ Breast Cancers | 1-gen-2014 | Bravaccini, S; Tumedei, Mm; Scarpi, E; Zoli, W; Rengucci, C; Serra, L; Curcio, A; Buggi, F; Folli, S; Rocca, A; Maltoni, R; Puccetti, M; Amadori, D; Silvestrini, R | |
| Assessment of DNA Damage and Telomerase Activity in Exfoliated Urinary Cells as Sensitive and Noninvasive Biomarkers for Early Diagnosis of Bladder Cancer in Ex-Workers of a Rubber Tyres Industry | 1-gen-2014 | Cavallo, D; Casadio, V; Bravaccini, S; Iavicoli, S; Pira, E; Romano, C; Fresegna, Am; Maiello, R; Ciervo, A; Buresti, G; Zoli, W; Calistri, D | |
| Benefit from anthracyclines in relation to biological profiles in early breast cancer | 1-gen-2014 | Rocca, A; Bravaccini, S; Scarpi, E; Mangia, A; Petroni, S; Puccetti, M; Medri, L; Serra, L; Ricci, M; Cerasoli, S; Biglia, N; Maltoni, R; Giunchi, Dc; Gianni, L; Tienghi, A; Brandi, M; Faedi, M; Sismondi, P; Paradiso, A; Silvestrini, R; Amadori, D | |
| Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast | 1-gen-2015 | Tumedei, Mm; Silvestrini, R; Ravaioli, S; Massa, I; Maltoni, R; Rocca, A; Folli, S; Buggi, F; Curcio, A; Serra, L; Puccetti, M; Amadori, D; Bravaccini, S | |
| Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy | 1-gen-2015 | Rocca, A; Andreis, D; Fedeli, A; Maltoni, R; Sarti, S; Cecconetto, L; Pietri, E; Schirone, A; Bravaccini, S; Serra, P; Farolfi, A; Amadori, D | |
| In-111-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance | 1-gen-2015 | Genestreti, G; Bongiovanni, A; Burgio, Ma; Burgio, Sl; Musto, A; Rossi, A; Monti, M; Scarpi, E; Ulivi, P; Bravaccini, S; Dubini, A; Matteucci, F; Gavelli, G | |
| Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in patients with different subtypes of breast cancer | 1-gen-2016 | Ravaioli, S; Maltoni, R; Casadio, V; Tumedei, Mm; Foca, F; Salvi, S; Martignano, F; Calistri, D; Rocca, A; Bravaccini, S | |
| ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA | 1-gen-2016 | Bravaccini, S; Tumedei, Mm; Ulivi, P; Zoli, W; Calistri, D; Candoli, P; Amadori, D; Puccetti, M | |
| Androgen receptor signaling pathways as a target for breast cancer treatment | 1-gen-2016 | Pietri, E; Conteduca, V; Andreis, D; Massa, I; Melegari, E; Sarti, S; Cecconetto, L; Schirone, A; Bravaccini, S; Serra, P; Fedeli, A; Maltoni, R; Amadori, D; De Giorgi, U; Rocca, A | |
| Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report | 1-gen-2016 | Gardini, Ac; Mariotti, M; Lucchesi, A; Pini, S; Valgiusti, M; Bravaccini, S; Del Monte, A; Burgio, Ma; Marisi, G; Amadori, D; Frassineti, Gl | |
| Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy | 1-gen-2016 | Ulivi, P; Chiadini, E; Dazzi, C; Dubini, A; Costantini, M; Medri, L; Puccetti, M; Capelli, L; Calistri, D; Verlicchi, A; Gamboni, A; Papi, M; Mariotti, M; De Luigi, N; Scarpi, E; Bravaccini, S; Turolla, Gm; Amadori, D; Crino, L; Delmonte, A | |
| Frequency of Actionable Alterations in EGFR wt NSCLC: Experience of the Wide Catchment Area of Romagna (AVR) | 1-gen-2017 | Chiadini, E; Delmonte, A; Capelli, L; De Luigi, N; Gamboni, A; Casanova, C; Dazzi, C; Papi, M; Bravaccini, S; Tumedei, Mm; Dubini, A; Puccetti, M; Crino, L; Uliyil, P | |
| Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer | 1-gen-2017 | Maltoni, R; Casadio, V; Ravaioli, S; Foca, F; Tumedei, Mm; Salvi, S; Martignano, F; Calistri, D; Rocca, A; Schirone, A; Amadori, D; Bravaccini, S | |
| Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization | 1-gen-2017 | Ravaioli, S; Tumedei, Mm; Amadori, A; Puccetti, M; Chiadini, E; Bravaccini, S | |
| Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania | 1-gen-2017 | Masalu, N; Serra, P; Amadori, D; Kahima, J; Majinge, C; Rwehabura, J; Nanni, O; Bravaccini, S; Puccetti, M; Tumino, R; Bucchi, L | |
| Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology | 1-gen-2017 | Ravaioli, S; Bravaccini, S; Tumedei, Mm; Pironi, F; Candoli, P; Puccetti, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile